Page last updated: 2024-10-20

phosphorylethanolamine and Diseases in Twins

phosphorylethanolamine has been researched along with Diseases in Twins in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Diseases in Twins: Disorders affecting TWINS, one or both, at any age.

Research Excerpts

ExcerptRelevanceReference
"A kindred with dominant hypophosphatasia resulting from an alanine to threonine substitution at position 99 of the alkaline phosphatase protein is described."3.70Characterization of a family with dominant hypophosphatasia. ( Hu, JC; Mornet, E; Plaetke, R; Simmer, JP; Sun, X; Thomas, HF; Zhang, C, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hu, JC1
Plaetke, R1
Mornet, E1
Zhang, C1
Sun, X1
Thomas, HF1
Simmer, JP1

Other Studies

1 other study available for phosphorylethanolamine and Diseases in Twins

ArticleYear
Characterization of a family with dominant hypophosphatasia.
    European journal of oral sciences, 2000, Volume: 108, Issue:3

    Topics: Alanine; Alkaline Phosphatase; Amino Acid Substitution; Child; Dental Cementum; Dental Enamel Hypopl

2000